Requires health insurers to provide coverage for opioid antagonists and devices

This bill requires health insurers to cover at least one opioid antagonist (like naloxone) and related devices in all prescription drug plans. It directly affects insurers, patients at risk of opioid overdose, and healthcare providers who can prescribe these medications via standing orders. The law mandates coverage without eliminating deductibles or co-insurance, which may apply as they do for other covered treatments. Naloxone is specifically named as the primary opioid antagonist to be covered, as defined by the FDA and New York’s Department of Health.